Gilead Sciences (GILD)

AI-powered earnings call analysis for Gilead Sciences. Get insights from quarterly earnings reports with our AI-generated podcast. Educational content only - not investment advice.

10 episodes 5 languages

Next Episode

Gilead Sciences earnings call scheduled for Aug 6, 2026 (after market close)

New episode expected Aug 7, 2026

Latest Episode

Q1 2026 Earnings

8:09 • 5/8/2026

Gilead Sciences (GILD) - Q1 2026

0:00

8:09

Speed:

Q1 2026 Earnings

11:56 • 2026/5/8

Gilead Sciences (GILD) - Q1 2026

0:00

11:56

Speed:

Q1 2026 Earnings

9:16 • 08/05/2026

Gilead Sciences (GILD) - Q1 2026

0:00

9:16

Speed:

Q1 2026 Earnings

12:40 • 8/5/2026

Gilead Sciences (GILD) - Q1 2026

0:00

12:40

Speed:

Q1 2026 Earnings

11:07 • 8.5.2026

Gilead Sciences (GILD) - Q1 2026

0:00

11:07

Speed:

All Episodes

EN - English (2) CN - 中文 (2) FR - Français (2) ES - Español (2) DE - Deutsch (2)

Q1 2026 Earnings

8:09

Gilead delivered Q1 2026 product sales of $6.9B (+5% YoY) with HIV growth of 10% and Yes2Go blockbuster trajectory, raising full-year guidance $400M while closing transformational acquisitions in oncology and cell therapy.